This trial is testing a new combination of drugs to treat glioblastoma, a type of brain cancer.
1 Primary · 5 Secondary · Reporting Duration: At Month 18
Experimental Treatment
52 Total Participants · 2 Treatment Groups
Primary Treatment: INO-5401 · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:California | 100.0% |
Met criteria | 100.0% |